Phibro Animal Health Shares Maintain Strong Momentum on Robust Financials

Phibro Animal Health Corporation continues to demonstrate remarkable market performance, driven by exceptional fiscal results and strategic expansion within the animal health industry. Recent financial disclosures for fiscal year 2025 reveal substantial growth across key revenue and profit metrics.

The company reported consolidated net revenue of $378.7 million for its fourth quarter, representing a 39 percent increase compared to the same period last year. For the full fiscal year 2025, revenues reached $1.296 billion, marking a 27 percent year-over-year expansion.

This impressive growth was primarily fueled by the company’s Animal Health division, which delivered outstanding results:
* Quarterly revenue increase: 53%
* Annual revenue growth: 36%
* Full-year adjusted EBITDA: +65%
* Net income: surged to $48.26 million (from $2.42 million in 2024)

Strategic Acquisition Powers Expansion

A... Read more...